RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility Type 4 NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Cancer Risk
The RAD51D Gene Breast-Ovarian Cancer Familial Susceptibility Type 4 NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment. This advanced diagnostic tool utilizes next-generation sequencing (NGS) technology to analyze the RAD51D gene, which plays a critical role in DNA repair mechanisms. When mutations occur in this gene, individuals face significantly elevated risks for developing breast and ovarian cancers throughout their lifetime.
What Does This Test Measure?
This comprehensive genetic analysis specifically targets the RAD51D gene to identify pathogenic variants that disrupt normal DNA repair processes. The test examines:
- Complete sequencing of the RAD51D gene coding regions
- Detection of point mutations, insertions, and deletions
- Identification of known pathogenic variants associated with cancer susceptibility
- Assessment of variant classification according to ACMG guidelines
Who Should Consider RAD51D Genetic Testing?
This test is particularly recommended for individuals with:
- Personal history of breast cancer diagnosed before age 50
- Family history of multiple breast and/or ovarian cancer cases
- Known RAD51D mutations in family members
- Ashkenazi Jewish ancestry with cancer family history
- Bilateral breast cancer or both breast and ovarian cancer
- Male breast cancer in the family
Key Benefits of RAD51D Genetic Testing
- Early Risk Identification: Detect cancer predisposition before disease development
- Personalized Prevention: Implement targeted screening and surveillance protocols
- Family Planning Guidance: Inform reproductive decisions and family risk assessment
- Treatment Optimization: Guide surgical and therapeutic choices for affected individuals
- Peace of Mind: Reduce uncertainty through definitive genetic information
Understanding Your Test Results
Your genetic test results will fall into one of three categories:
- Positive Result: A pathogenic RAD51D mutation is identified, indicating increased cancer risk and necessitating enhanced surveillance and preventive measures
- Negative Result: No RAD51D mutation detected, though family cancer patterns should still guide screening recommendations
- Variant of Uncertain Significance (VUS): A genetic change with unknown clinical significance requiring ongoing monitoring and family studies
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our certified genetic counselors are available to provide comprehensive pre-test and post-test counseling sessions.
Take Control of Your Genetic Health Today
Don’t wait to understand your cancer risk profile. Our team of board-certified genetic counselors and oncology specialists are ready to guide you through the testing process and help you develop a personalized cancer prevention strategy. Schedule your RAD51D genetic testing appointment today by calling +1(267) 388-9828 or booking online through our secure patient portal.
Important Note: All testing includes mandatory genetic counseling to ensure proper interpretation of results and development of appropriate medical management plans based on your individual risk assessment.
